Back to results
US 9,427,398 B2Granted
Parenteral solutions containing metolazone
AssigneeAcademic Pharmaceuticals, Inc.
InventorsJohn Somberg, Vasant Ranade
Life of this patent
Estimating the term…
Abstract
Disclosed herein are parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamide in N,N-dimethylacetamide, polyethylene glycol and D5W useful in the treatment of hypertension, heart failure and renal disease leading to edematous states. Also disclosed are methods for preparing such solutions.
Claims18
A method of a treating a patient suffering from an edema, comprising:
- parenterally administering to the patient suffering from an edema a therapeutically effective amount of a solution, comprising:
- 1 to 15 mg/mL metolazone dissolved in up to 2% by volume N,N-dimethylacetamide (DMAC) and the remainder being 5% dextrose solution (D5W), wherein the pH of the solution is from 6.8-8.
Dependencies are inferred from the claim text.